Cargando…
Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation
Background and Objectives: It has been confirmed that adiponectin/leptin (A/L) ratio correlates better with cardiometabolic risk factors than hormone levels alone. The aim of our study was to determine the risk of developing post-transplant diabetes mellitus (PTDM) and other metabolic conditions dep...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695584/ https://www.ncbi.nlm.nih.gov/pubmed/36422195 http://dx.doi.org/10.3390/medicina58111656 |
_version_ | 1784838098025185280 |
---|---|
author | Graňák, Karol Vnučák, Matej Beliančinová, Monika Kleinová, Patrícia Pytliaková, Margaréta Miklušica, Juraj Dedinská, Ivana |
author_facet | Graňák, Karol Vnučák, Matej Beliančinová, Monika Kleinová, Patrícia Pytliaková, Margaréta Miklušica, Juraj Dedinská, Ivana |
author_sort | Graňák, Karol |
collection | PubMed |
description | Background and Objectives: It has been confirmed that adiponectin/leptin (A/L) ratio correlates better with cardiometabolic risk factors than hormone levels alone. The aim of our study was to determine the risk of developing post-transplant diabetes mellitus (PTDM) and other metabolic conditions depending on A/L ratio after kidney transplantation (KT). Material and Methods: In a prospective analysis, the studied samples were divided into three groups: control group, prediabetes and PTDM group. Pre-transplantation, at 3, 6 and 12 months after KT, we recorded basic characteristics of donor and recipient. We also monitored levels of adipocytokines and calculated A/L ratio. Results: During observed period, we recorded significant increase in A/L ratio in control group (p = 0.0013), on the contrary, a significant decrease in PTDM group (p = 0.0003). Using Cox regression Hazard model, we identified age at time of KT (HR 2.8226, p = 0.0225), triglycerides at 1 year (HR 3.5735, p = 0.0174) and A/L ratio < 0.5 as independent risk factors for prediabetes and PTDM 1-year post-transplant (HR 3.1724, p = 0.0114). Conclusions: This is the first study to evaluate the relationship between A/L and risk of PTDM and associated metabolic states after KT. We found out that A/L ratio <0.5 is independent risk factor for prediabetes and PTDM 1 year post-transplant. |
format | Online Article Text |
id | pubmed-9695584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96955842022-11-26 Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation Graňák, Karol Vnučák, Matej Beliančinová, Monika Kleinová, Patrícia Pytliaková, Margaréta Miklušica, Juraj Dedinská, Ivana Medicina (Kaunas) Article Background and Objectives: It has been confirmed that adiponectin/leptin (A/L) ratio correlates better with cardiometabolic risk factors than hormone levels alone. The aim of our study was to determine the risk of developing post-transplant diabetes mellitus (PTDM) and other metabolic conditions depending on A/L ratio after kidney transplantation (KT). Material and Methods: In a prospective analysis, the studied samples were divided into three groups: control group, prediabetes and PTDM group. Pre-transplantation, at 3, 6 and 12 months after KT, we recorded basic characteristics of donor and recipient. We also monitored levels of adipocytokines and calculated A/L ratio. Results: During observed period, we recorded significant increase in A/L ratio in control group (p = 0.0013), on the contrary, a significant decrease in PTDM group (p = 0.0003). Using Cox regression Hazard model, we identified age at time of KT (HR 2.8226, p = 0.0225), triglycerides at 1 year (HR 3.5735, p = 0.0174) and A/L ratio < 0.5 as independent risk factors for prediabetes and PTDM 1-year post-transplant (HR 3.1724, p = 0.0114). Conclusions: This is the first study to evaluate the relationship between A/L and risk of PTDM and associated metabolic states after KT. We found out that A/L ratio <0.5 is independent risk factor for prediabetes and PTDM 1 year post-transplant. MDPI 2022-11-16 /pmc/articles/PMC9695584/ /pubmed/36422195 http://dx.doi.org/10.3390/medicina58111656 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Graňák, Karol Vnučák, Matej Beliančinová, Monika Kleinová, Patrícia Pytliaková, Margaréta Miklušica, Juraj Dedinská, Ivana Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation |
title | Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation |
title_full | Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation |
title_fullStr | Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation |
title_full_unstemmed | Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation |
title_short | Adiponectin/Leptin Ratio as an Index to Determine Metabolic Risk in Patients after Kidney Transplantation |
title_sort | adiponectin/leptin ratio as an index to determine metabolic risk in patients after kidney transplantation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695584/ https://www.ncbi.nlm.nih.gov/pubmed/36422195 http://dx.doi.org/10.3390/medicina58111656 |
work_keys_str_mv | AT granakkarol adiponectinleptinratioasanindextodeterminemetabolicriskinpatientsafterkidneytransplantation AT vnucakmatej adiponectinleptinratioasanindextodeterminemetabolicriskinpatientsafterkidneytransplantation AT beliancinovamonika adiponectinleptinratioasanindextodeterminemetabolicriskinpatientsafterkidneytransplantation AT kleinovapatricia adiponectinleptinratioasanindextodeterminemetabolicriskinpatientsafterkidneytransplantation AT pytliakovamargareta adiponectinleptinratioasanindextodeterminemetabolicriskinpatientsafterkidneytransplantation AT miklusicajuraj adiponectinleptinratioasanindextodeterminemetabolicriskinpatientsafterkidneytransplantation AT dedinskaivana adiponectinleptinratioasanindextodeterminemetabolicriskinpatientsafterkidneytransplantation |